[1]
|
Zhang, L., Wang, F., Wang, L., et al. (2012) Prevalence of Chronic Kidney Disease in China: A Cross-Sectional Survey. The Lancet, 379, 815-822. https://doi.org/10.1016/S0140-6736(12)60033-6
|
[2]
|
《中国腹膜透析管理现状白皮书》项目组. 中国腹膜透析管理现状白皮书[J]. 中华肾脏病杂志, 2022(12): 1076-1104.
|
[3]
|
Wolfe, R.A., Ashby, V.B., Milford, E.L., et al. (1999) Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Trans-plantation, and Recipients of a First Cadaveric Transplant. The New England Journal of Medicine, 341, 1725-1730. https://doi.org/10.1056/NEJM199912023412303
|
[4]
|
Ekberg, H., Tedesco-Silva, H., Demirbas, A., et al. (2007) Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. The New England Journal of Medicine, 357, 2562-2575. https://doi.org/10.1056/NEJMoa067411
|
[5]
|
Locke, J.E. (2018) Handbook of Kidney Transplantation. Sixth Edition G. M. Danovitch (Editor) Wolters Kluwar, 2017, 606pp. ISBN: 9781496326157. American Journal of Transplantation, 18, 1820.
https://doi.org/10.1111/ajt.14906
|
[6]
|
Rike, A.H., Mogilishetty, G., Alloway, R.R., et al. (2010) Cardiovascular Risk, Cardiovascular Events, and Metabolic Syndrome in Renal Transplantation: Comparison of Early Steroid Withdraw-al and Chronic Steroids. Clinical Transplantation, 22, 229-235. https://doi.org/10.1111/j.1399-0012.2007.00779.x
|
[7]
|
Veenstra, D.L., Best, J.H., Hornberger, J., et al. (1999) In-cidence and Long-Term Cost of Steroid-Related Side Effects after Renal Transplantation. American Journal of Kidney Diseases, 33, 829-839.
https://doi.org/10.1016/S0272-6386(99)70414-2
|
[8]
|
Rangaswami, J., Mathew, R.O., Parasuraman, R., et al. (2019) Cardiovascular Disease in the Kidney Transplant Recipient: Epidemiology, Diagnosis and Management Strategies. Nephrology Dialysis Transplantation, 34, 760-773.
https://doi.org/10.1093/ndt/gfz053
|
[9]
|
De Lucena, D.D. and Rangel, É.B. (2018) Glucocorticoids Use in Kidney Transplant Setting. Expert Opinion on Drug Metabolism & Toxicology, 14, 1023-1041. https://doi.org/10.1080/17425255.2018.1530214
|
[10]
|
Stoumpos, S., Jardine, A.G. and Mark, P.B. (2015) Cardio-vascular Morbidity and Mortality after Kidney Transplantation. Transplant International, 28, 10-21. https://doi.org/10.1111/tri.12413
|
[11]
|
Ojo, A.O. (2006) Cardiovascular Complications after Renal Transplantation and Their Prevention. Transplantation, 82, 603-611. https://doi.org/10.1097/01.tp.0000235527.81917.fe
|
[12]
|
Knight, S.R. and Morris, P.J. (2010) Steroid Avoidance or Withdrawal after Renal Transplantation Increases the Risk of Acute Rejection but Decreases Cardiovascular Risk. A Me-ta-Analysis. Transplantation, 89, 1-14.
https://doi.org/10.1097/TP.0b013e3181c518cc
|
[13]
|
Taber, D.J., Hunt, K.J., Gebregziabher, M., et al. (2017) A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology, 12, 131-139.
https://doi.org/10.2215/CJN.04880516
|
[14]
|
Thomusch, O., Wiesener, M., Opgenoorth, M., et al. (2016) Rab-bit-ATG or Basiliximab Induction for Rapid Steroid Withdrawal after Renal Transplantation (Harmony): An Open-Label, Multicentre, Randomised Controlled Trial. The Lancet, 388, 3006-3016. https://doi.org/10.1016/S0140-6736(16)32187-0
|
[15]
|
Rhen, T. and Cidlowski, J.A. (2005) Antiinflammatory Ac-tion of Glucocorticoids—New Mechanisms for Old Drugs. The New England Journal of Medicine, 353, 1711-1723. https://doi.org/10.1056/NEJMra050541
|
[16]
|
王振, 付迎欣. 糖皮质激素在肾移植中的应用[J]. 实用器官移植电子杂志, 2014(2): 83-86.
|
[17]
|
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. American Journal of Transplantation, 9, S1-S155.
https://doi.org/10.1111/j.1600-6143.2009.02834.x
|
[18]
|
Webster, A.C., Woodroffe, R.C., Taylor, R.S., et al. (2005) Tacrolimus versus Ciclosporin as Primary Immunosuppression for Kidney Transplant Recipients: Meta-Analysis and Meta-Regression of Randomised Trial Data. BMJ, 331, 810. https://doi.org/10.1136/bmj.38569.471007.AE
|
[19]
|
Knight, S.R., Russell, N.K., Barcena, L., et al. (2009) Myco-phenolate Mofetil Decreases Acute Rejection and May Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review. Transplantation, 87, 785-794. https://doi.org/10.1097/TP.0b013e3181952623
|
[20]
|
Ekberg, J., Baid-Agrawal, S., Jespersen, B., et al. (2021) A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipi-ents. Kidney International Reports, 7, 259-269.
https://doi.org/10.1016/j.ekir.2021.11.028
|
[21]
|
Van Sandwijk, M.S., De Vries, A.P.J., Bakker, S.J.L., et al. (2018) Early Steroid Withdrawal Compared with Standard Immunosuppression in Kidney Transplantation—Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial. Transplantation Direct, 4, e354. https://doi.org/10.1097/TXD.0000000000000794
|
[22]
|
Krämer, B.K., Klinger, M., Vítko, Š., et al. (2012) Tacroli-mus-Based, Steroid-Free Regimens in Renal Transplantation: 3-Year Follow-Up of the ATLAS Trial. Transplantation, 94, 492-498. https://doi.org/10.1097/TP.0b013e31825c1d6c
|
[23]
|
Mourad, G., Glyda, M., Albano, L., et al. (2017) Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Pro-longed-Release Tacrolimus-Based Immunosuppression with 2 Different Corticosteroid Minimization Strategies: ADVANCE, a Randomized Controlled Trial. Transplantation, 101, 1924-1934.
https://doi.org/10.1097/TP.0000000000001453
|
[24]
|
Woodle, E.S., First, M.R., Pirsch, J., et al. (2008) A Prospec-tive, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation versus Long-Term, Low-Dose Corticosteroid Therapy. Annals of Surgery, 248, 564-577. https://doi.org/10.1097/SLA.0b013e318187d1da
|
[25]
|
Woodle, E.S., Gill, J.S., Clark, S., et al. (2021) Early Corti-costeroid Cessation vs Long-Term Corticosteroid Therapy in Kidney Transplant Recipients: Long-Term Outcomes of a Randomized Clinical Trial. JAMA Surgery, 156, 307-314.
https://doi.org/10.1001/jamasurg.2020.6929
|
[26]
|
Nagib, A.M., Abbas, M.H., Abu-Elmagd, M.M., et al. (2015) Long-Term Study of Steroid Avoidance in Renal Transplant Patients: A Single-Center Experience. Transplantation Pro-ceedings, 47, 1099-1104.
https://doi.org/10.1016/j.transproceed.2014.11.063
|
[27]
|
Gheith, O.A., Nematalla, A.H., Bakr, M.A., et al. (2011) Steroid Avoidance Reduce the Cost of Morbidities after Live-Donor Renal Allotransplants: A Prospective, Randomized, Controlled Study. Experimental and Clinical Transplantation, 9, 121-127.
|
[28]
|
Garcia, V.D., Carvalho, D.B.M., Gon-calves, R.T., et al. (2008) Corticosteroid Reduction with Tacrolimus (CORRETA) TRIAL: A Prospective Brazilian Mul-ticenter, Randomized Trial of Early Corticosteroid Reduction versus Regular Corticosteroid Dosage Maintenance on a Tacrolimus (Prograf) and Mycophenolate Mofetil (Cellcept) Immunosuppression Regimen in Kidney Transplant Recipi-ents: Interim Analysis. Transplantation Proceedings, 40, 689-692.
https://doi.org/10.1016/j.transproceed.2008.03.015
|
[29]
|
Hernández, D., Alonso-Titos, J., Vázquez, T., et al. (2021) Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients. Journal of Clinical Medicine, 10, 2005.
https://doi.org/10.3390/jcm10092005
|
[30]
|
Vazquez, T., Alonso-Titos, J., Gamez, J.P., et al. (2018) Effect of Ster-oid Withdrawal on the Appearance of de Novo Donor-Specific HLA Antibodies in Kidney Transplant Recipients: A Prospective, Randomized, Controlled, Parallel Group Study. Preliminary Results. Transplantation, 102, S203. https://doi.org/10.1097/01.tp.0000542857.44740.52
|
[31]
|
Oh, C.K., Kim, S.J., Kim, J.H., et al. (2012) Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients. Journal of Korean Medical Science, 27, 337-342. https://doi.org/10.3346/jkms.2012.27.4.337
|
[32]
|
Zhu, Q.G., Zhao, Y.K., Liu, W., et al. (2008) Two-Year Observa-tion of a Randomized Trial on Tacrolimus-Based Therapy with Withdrawal of Steroids or Mycophenolate Mofetil after Renal Transplantation. Chinese Medical Sciences Journal, 23, 244-248. https://doi.org/10.1016/S1001-9294(09)60047-X
|
[33]
|
Desai, V.C.A., Ferrand, Y., Cavanaugh, T.M., et al. (2017) Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Trans-plantation: Results from Discrete Event Simulation. Medical Decision Making, 37, 827-843. https://doi.org/10.1177/0272989X17700879
|
[34]
|
Alonso-Titos, J., Ruiz-Esteban, P., Palma, E., et al. (2017) De Novo Donor-Specific HLA Antibodies after Steroid Withdrawal in Kidney Transplant Recipients: A Prospective, Ran-domized, Controlled, Parallel Group Study. Preliminary Results. Transplant International, 30, 243.
|
[35]
|
Hardinger, K.L., Brennan, D.C. and Klein, C.L. (2013) Selection of Induction Therapy in Kidney Transplantation. Transplant Internation-al, 26, 662-672. https://doi.org/10.1111/tri.12043
|